ALK inhibitor 2

CAS No. 761438-38-4

ALK inhibitor 2 ( ALK inhibitor 2; MDK-8384; MDK 8384 )

Catalog No. M19086 CAS No. 761438-38-4

ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 149 Get Quote
5MG 228 Get Quote
10MG 320 Get Quote
25MG 530 Get Quote
50MG 758 Get Quote
100MG 1017 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ALK inhibitor 2
  • Note
    Research use only, not for human use.
  • Brief Description
    ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.
  • Description
    MDK-8384, also known as ALK inhibitor 2, is a potent and selective ALK inhibitor. MDK-8384 has CAS#761438-38-4. MDK-8384 was reported in J Med Chem. 2013;56(14):5675-90.
  • Synonyms
    ALK inhibitor 2; MDK-8384; MDK 8384
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ALK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    761438-38-4
  • Formula Weight
    518.03
  • Molecular Formula
    C23H28ClN7O3S
  • Purity
    98%
  • Solubility
    DMSO : 50 mg/mL 96.52 mM;H2O : < 0.1 mg/mL
  • SMILES
    c1cc(c(cc1)Nc1c(cnc(n1)Nc1c(cc(cc1)N1CCN(CC1)C)OC)Cl)S(=O)(=O)NC
  • Chemical Name
    2-[[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]-N-methylbenzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. A Dose Finding Study With Oral LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase (ALK).
molnova catalog
related products
  • N-Formyl-Met-Leu-Phe...

    N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.

  • Rezatomidine

    Rezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.

  • Benzylideneaniline

    Benzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.